RBC Capital Maintains Outperform on Albemarle, Lowers Price Target to $129
RBC Capital analyst Arun Viswanathan maintains Albemarle (NYSE:ALB) with a Outperform and lowers the price target from $157 to $129.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
RBC Capital analyst Arun Viswanathan maintains Albemarle (NYSE:ALB) with a Outperform and lowers the price target from $157 to $129.
Analysts upgraded ALB, LQDA, WY, RAL, setting or revising price targets to $130, $70, $25, $88.
Mizuho analyst John Roberts upgrades Albemarle (NYSE:ALB) from Neutral to Outperform and maintains the price target from $130 to $130.
Canaccord Genuity analyst George Gianarikas initiates coverage on Amprius Technologies (NYSE:AMPX) with a Buy rating and announces Price Target of $14.
-SEC Filing